Extended Data Fig. 8: Change of the accessibility of the individual peptide of C1QA (GFCDTTNKGLF, first column), CLUS (SVDCSTNNPSQAKL, second column) and APOB (AVLCEFISQSIKSF, third column) with longitudinal samples.
From: Structural signature of plasma proteins classifies the status of Alzheimer’s disease
Only SVDCSTNNPSQAKL exhibited the distinct change of the accessibility between the paired samples. Two-sided Wilcoxon test was performed. *, P-value = 0.0137.
